inCerebro adopts CDD Vault to enhance its capabilities

inCerebro, a pharmaceutical research and development company, has officially adopted CDD Vault^® from Collaborative Drug Discovery (CDD). CDD Vault is a secure, cloud-based informatics platform designed to centralise and streamline data management in drug discovery.

For inCerebro, using CDD Vault means faster data sharing, more efficient analysis, and improved collaboration across research teams. The platform’s advanced data visualisation tools and straightforward interface allow inCerebro’s scientists to dive into the data with greater ease, aiding in critical decision making and keeping research efforts on the fast track.

This partnership with CDD Vault underscores inCerebro’s commitment to driving forward computational drug discovery, promising more efficient workflows and enhancing collaboration in the pursuit of life-changing therapies.

inCerebro’s research activities focus on a unique combination of artificial intelligence (AI), physics-based methods, and quantum computing to drive drug discovery. With the inCerebro MIND platform at the helm, the company incorporates AI wherever possible to optimize each module, all backed by rigorous computer simulations grounded in physical laws.

Dr Art Cho, Chief Executive Officer at inCerebro, enthused, “With CDD Vault, we’re gaining a sophisticated platform to manage our complex data in a way that enhances our work rather than complicates it. Our inCerebro MIND platform relies on the seamless integration of AI and quantum mechanics-based simulations, and now, thanks to CDD Vault, we can manage and analyse our data more intuitively, freeing up our team to focus on what we do best – discovering novel therapies.”

Want the latest science news straight to your inbox? Become a SelectScience member for free today>>